Butler John P.
CIK: 0001591467•CEO and President
OfficerDirector
Primary company: Akebia Therapeutics, Inc. (AKBA)
Butler John P. is a corporate insider (CEO and President) at Akebia Therapeutics, Inc. (AKBA) filing SEC Form 4 transactions. 93 transactions across 4 companies, totaling $267,603 in purchases and $1,083,468 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 350,000 | $0.63 | $221K | 525,000 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Exercise | 350,000 | $0.63 | $221K | 3,718,564 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Sale | 46,409 | $1.83 | $85K | 2,557,921 | 3/3/2025 Filed: 3/4/2025 | Filing → | |
| Sale | 97,982 | $2.10 | $206K | 2,604,330 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Sale | 46,268 | $2.10 | $97K | 2,702,312 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Award | 1,051,400 | $2.24 | $2.36M | 1,051,400 | 1/31/2025 Filed: 2/4/2025 | Filing → | |
| Award | 350,500 | - | - | 350,500 | 1/31/2025 Filed: 2/4/2025 | Filing → | |
| Award | 701,000 | - | - | 2,748,580 | 1/31/2025 Filed: 2/4/2025 | Filing → | |
| Sale | 46,570 | $1.58 | $74K | 2,044,580 | 2/29/2024 Filed: 3/1/2024 | Filing → | |
| Sale | 37,733 | $1.52 | $57K | 2,091,150 | 2/27/2024 Filed: 2/29/2024 | Filing → | |
| Sale | 46,489 | $1.68 | $78K | 2,128,883 | 2/1/2024 Filed: 2/2/2024 | Filing → | |
| Award | 905,200 | - | - | 905,200 | 1/31/2024 Filed: 2/2/2024 | Filing → | |
| Award | 603,500 | - | - | 2,175,372 | 1/31/2024 Filed: 2/2/2024 | Filing → | |
Zynerba Pharmaceuticals, Inc. ZYNE | Disposition | 71,736 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Disposition | 34,663 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 47,824 | - | - | 0 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | U | 32,941 | - | - | 47,824 | 10/10/2023 Filed: 10/11/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Sale | 115 | $0.35 | $40 | 80,765 | 6/14/2023 Filed: 6/15/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 71,736 | $0.00 | $0 | 71,736 | 6/13/2023 Filed: 6/15/2023 | Filing → |
Zynerba Pharmaceuticals, Inc. ZYNE | Award | 47,824 | $0.00 | $0 | 80,880 | 6/13/2023 Filed: 6/15/2023 | Filing → |
Type
Exercise
Shares
350,000
Price
$0.63
Value
$221K
Type
Exercise
Shares
350,000
Price
$0.63
Value
$221K
Type
Sale
Shares
46,409
Price
$1.83
Value
$85K
Type
Sale
Shares
97,982
Price
$2.10
Value
$206K
Type
Sale
Shares
46,268
Price
$2.10
Value
$97K
Type
Award
Shares
1,051,400
Price
$2.24
Value
$2.36M
Type
Award
Shares
350,500
Price
-
Value
-
Type
Award
Shares
701,000
Price
-
Value
-
Type
Sale
Shares
46,570
Price
$1.58
Value
$74K
Type
Sale
Shares
37,733
Price
$1.52
Value
$57K
Type
Sale
Shares
46,489
Price
$1.68
Value
$78K
Type
Award
Shares
905,200
Price
-
Value
-
Type
Award
Shares
603,500
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Disposition
Shares
71,736
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Disposition
Shares
34,663
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
47,824
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
U
Shares
32,941
Price
-
Value
-
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Sale
Shares
115
Price
$0.35
Value
$40
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
71,736
Price
$0.00
Value
$0
Zynerba Pharmaceuticals, Inc.
ZYNE
Type
Award
Shares
47,824
Price
$0.00
Value
$0
AI Agent
Try asking...